068760 fundamentals
An in-depth look to CELLTRION PHARM INC. operating, investing, and financing activities
068760 free cash flow for Q2 24 is -14.63 B KRW. For 2023, 068760 free cash flow was -3.14 B KRW and operating cash flow was 1.81 B KRW.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM